AMERICAN BATTERY TECHNOLOGY Co
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
ABAT$1.32-7.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (unaudited)
Three months ended March 31, 2024:
| Common Shares · Additional Paid-In · Common Stock · Accumulated | ||||||
|---|---|---|---|---|---|---|
| Number | Amount | Capital | Issuable | Deficit | Total | |
| Balance, December 31, 2023 | 49,343,225 | $49,345 | $243,823,714 | - | $(179,896,345) | $63,976,714 |
| Vesting of share-based awards | 597,019 | 597 | (597) | - | - | - |
| Stock-based compensation expense | - | - | 4,089,033 | - | - | 4,089,033 |
| Shares issued pursuant to share purchase agreement, net of issuance costs | 5,103,037 | 5,102 | 11,493,171 | 499,681 | - | 11,997,954 |
| Shares issued pursuant to warrant exercises | 15,130 | 15 | (15) | - | - | - |
| Net loss for the period | - | - | - | - | (9,995,137) | (9,995,137) |
| Balance, March 31, 2024 | 55,058,411 | $55,059 | $259,405,304 | $499,681 | $(189,891,481) | $70,068,563 |
Three months ended March 31, 2023:
| Common Shares · Additional Paid-In · Common Stock Issuable · Accumulated | ||||||
|---|---|---|---|---|---|---|
| Number | Amount | Capital | (receivable) | Deficit | Total | |
| Balance, December 31, 2022 | 43,341,065 | $43,342 | $193,785,953 | $(646,177) | $(147,266,792) | $45,916,326 |
| Shares issued for professional services | - | - | - | 10,596 | - | 10,596 |
| Vesting of share-based awards | 172,095 | 172 | (172) | - | - | - |
| Stock-based compensation expense | - | - | 2,555,584 | - | - | 2,555,584 |
| Shares issued from purchase agreements | 133,333 | 133 | 1,550,266 | 654,267 | 2,204,666 | |
| Shares issued from private placement, net of issuance costs | 952,381 | 952 | 8,856,399 | - | - | 8,857,351 |
| Net loss for the period | - | - | - | - | (5,608,021) | (5,608,021) |
| Balance, March 31, 2023 | 44,598,874 | $44,599 | $206,748,030 | $18,686 | $(152,874,813) | $53,936,502 |
Condensed Consolidated Statements of Stockholders’ Equity (unaudited)
Nine months ended March 31, 2024:
| Common Shares · Additional Paid-In · Common Stock Issuable · Accumulated | ||||||
|---|---|---|---|---|---|---|
| Number | Amount | Capital | (receivable) | Deficit | Total | |
| Balance, June 30, 2023 | 45,888,131 | $45,887 | $222,301,371 | $(1,484,693) | $(160,826,508) | $60,036,057 |
| Shares issued for professional services | 1,326 | 1 | 15,172 | (15,307) | - | (134) |
| Vesting of share-based awards | 909,972 | 913 | (913) | - | - | - |
| Stock-based compensation expense | - | - | 10,975,214 | - | - | 10,975,214 |
| Shares issued pursuant to rounding of share reverse split | 59,164 | 59 | (59) | - | - | - |
| Shares reclaimed pursuant to asset acquisition | (128,206) | (128) | (1,255,650) | 1,500,000 | - | 244,222 |
| Shares issued pursuant to share purchase agreement | 8,209,262 | 8,208 | 27,332,791 | 499,681 | - | 27,840,680 |
| Shares issued pursuant to share private agreement, net of issuance costs | - | - | - | - | - | - |
| Shares issued pursuant to warrant exercises | 118,762 | 119 | 37,379 | - | - | 37,498 |
| Net loss for the period | - | - | - | - | (29,064,973) | (29,064,973) |
| Balance, March 31, 2024 | 55,058,411 | $55,059 | $259,405,304 | $499,681 | $(189,891,481) | $70,068,563 |
Nine months ended March 31, 2023:
| Common Shares · Additional Paid-In · Common Stock Issuable · Accumulated | ||||||
|---|---|---|---|---|---|---|
| Number | Amount | Capital | (receivable) | Deficit | Total | |
| Balance, June 30, 2022 | 42,942,576 | $42,943 | $188,151,484 | $75,000 | $(138,635,368) | $49,634,059 |
| Shares issued for professional services | 10,009 | 10 | 103,579 | (56,314) | - | 47,275 |
| Vesting of share-based awards | 293,908 | 294 | (294) | - | - | - |
| Stock-based compensation expense | - | - | 6,078,889 | - | - | 6,078,889 |
| Shares issued from purchase agreement | 400,000 | 400 | 3,557,973 | - | - | 3,558,373 |
| Shares issued from private placement, net of issuance costs | 952,381 | 952 | 8,856,399 | - | - | 8,857,351 |
| Net loss for the period | - | - | - | - | (14,239,445) | (14,239,445) |
| Balance, March 31, 2023 | 44,598,874 | $44,599 | $206,748,030 | $18,686 | $(152,874,813) | $53,936,502 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.